Evidence map›Paper›PMID 30583601›Full record

ArticlePharmaceutics2018

Effect of Shape on Mesoporous Silica Nanoparticles for Oral Delivery of Indomethacin.

Wei Zhang, Nan Zheng, Lu Chen, Luyao Xie, Mingshu Cui, Sanming Li, Lu Xu

Abstract read
In one paragraph

Article in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. A basedMaterials today. Bio · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei ZhangSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. zhangwei9501@126.com.
Nan ZhengSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. zhengnangg@hotmail.com.
Lu ChenSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. chenlu182125@163.com.
Luyao XieSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. xieluyao0221@163.com.
Mingshu CuiSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. cui_mingshu@126.com.
Sanming LiSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. lisanming2018@163.com.
Lu XuSchool of Pharmacy, Shenyang Pharmaceutical University, Wenhua RD 103, Shenyang 110016, China. xulu@syphu.edu.cn.

Funding

Shenyang Science and Technology Project No.17231139
6 · The paper itself

Abstract

The use of mesoporous silica nanoparticles (MSNs) in the field of oral drug delivery has recently attracted greater attention. However, there is still limited knowledge about how the shape of MSNs affects drug delivery capacity. In our study, we fabricated mesoporous silica nanorods (MSNRs) to study the shape effects of MSNs on oral delivery. MSNRs were characterized by transmission electron microscopy (TEM), nitrogen adsorption/desorption, Fourier transform infrared spectroscopy (FTIR), and small-angle X-ray diffraction (small-angle XRD). Indomethacin (IMC), a non-steroidal anti-inflammatory agent, was loaded into MSNRs as model drug, and the drug-loaded MSNRs resulted in an excellent dissolution-enhancing effect. The cytotoxicity and in vivo pharmacokinetic studies indicated that MSNRs can be applied as a safe and efficient candidate for the delivery of insoluble drugs. The use of MSNs with a rod-like shape, as a drug delivery carrier, will extend the pharmaceutical applications of silica materials.

Indexed as

drug deliveryindomethacinmesoporous silica nanoparticlesshape effect

Identifiers

PMID30583601
PMCPMC6359657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.